Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-07

Clinical Trial Update: The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates that Phase 2 and Phase 3 studies evaluating a flaxseed supplement for weight and biochemical factors in overweight/obese adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flaxseed supplement (Linum usitatissimum seed supplement)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Overweight and Obesity | Phase 2, Phase 3 | Status: COMPLETED